[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new biosimilar to Rituxan (rituximab) to treat several serious conditions. Riabni (rituximab-arrx) is the third approved biosimilar
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new oral hormone therapy for advanced prostate cancer. The FDA approved Orgovyx (relugolix) to treat adults who
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new treatment for non-small cell lung cancer (NSCLC). The FDA approved Tagrisso (osimertinib) to be used alongside
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has sent five companies warning letters for marketing products with cesium chloride. Cesium chloride, a dietary ingredient, may be found
[ad_1] (RxWiki News) Deaths from the most common type of lung cancer have decreased rapidly in recent years. Researchers are saying new treatments are behind this good news. A new
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication that can be given at home. This new medication is found under the
[ad_1] (RxWiki News) Johnson & Johnson has thousands of ongoing lawsuits because of its baby powder. Now, the product is leaving North American store shelves. As a result of ongoing
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new formulation of a drug that treats a type of blood cancer. Originally approved in 2015, Darzalex
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication. This new approval is called Trodelvy (sacituzumab govitecan-hziy). The FDA approved it to
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new breast cancer medication. This new approval is called Tukysa (tucatinib). The FDA approved it to treat
